Titre :
  • Pooled safety analysis of BAY 43-9006 (sorafenib) monotherapy in patients with advanced solid tumours: Is rash associated with treatment outcome?
Auteur : Strumberg, Dirk ; Awada, Ahmad ; Hirte, Hal W ; Clark, J W ; Seeber, Siegfried ; Piccart, P ; Hofstra, E ; Voliotis, Dimitris ; Christensen, O ; Brueckner, A ; Schwartz, Brian
Informations sur la publication : European journal of cancer, 42, 4, (page 548-556)
Statut de publication : Publié, 2006-03
Sujet CREF : Sciences bio-médicales et agricoles
Mots-clés : BAY 43-9006
PDGFR inhibitor
Phase I studies
Pooled analysis
Raf kinase inhibition
Refractory solid tumours
Sorafenib
VEGFR inhibitor
Mots-clés MeSH : Administration, Oral
Adolescent
Adult
Aged
Antineoplastic Agents -- adverse effects
Benzenesulfonates -- administration & dosage
Benzenesulfonates -- adverse effects
Clinical Trials, Phase I as Topic
Dose-Response Relationship, Drug
Drug Eruptions -- etiology
Exanthema -- chemically induced
Female
Humans
Male
Maximum Tolerated Dose
Middle Aged
Neoplasms -- drug therapy
Pyridines -- administration & dosage
Pyridines -- adverse effects
Treatment Outcome
Note : Journal Article
Meta-Analysis
Research Support, Non-U.S. Gov't
Langue :
  • Anglais
Identificateurs : urn:issn:0959-8049 
info:doi/10.1016/j.ejca.2005.11.014
info:pii/S0959-8049(05)01070-1
info:pmid/16426838